A Randomized, Placebo-Controlled Study of the Impact of the 7-Day Buprenorphine Transdermal System on Health-Related Quality of Life in Opioid-Naïve Patients With Moderate-to-Severe Chronic Low Back Pain-Reference-Cited by-同舟云学术

A Randomized, Placebo-Controlled Study of the Impact of the 7-Day Buprenorphine Transdermal System on Health-Related Quality of Life in Opioid-Naïve Patients With Moderate-to-Severe Chronic Low Back Pain

Published:2013-01 Issue:1 Volume:14 Page:14-23
ISSN:1526-5900
Container-title:The Journal of Pain
language:en
Short-container-title:The Journal of Pain

Author:

Yarlas Aaron,Miller Kate,Wen Warren,Dain Bradley,Lynch Shau Yu,Pergolizzi Joseph V.,Raffa Robert B.,Ripa Steven R.

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,Neurology

Reference40 articles.

1. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain;Allan;Spine (Phila Pa 1976),2005

2. Epidemiological features of chronic low-back pain;Andersson;Lancet,1999

3. Non-specific low back pain;Balague;Lancet,2012

4. Evidence for and against the use of opioid analgesics for chronic nonmalignant low back pain: A review;Bartleson;Pain Med,2002

5. Quality of life in chronic low back pain patients treated with instrumented fusion;Bentsen;J Clin Nurs,2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pain and function in patients with chronic low back pain and leg pain after Zhineng Qigong – a quasi-experimental feasibility study;BMC Musculoskeletal Disorders;2023-06-13

2. An Updated Overview of Low Back Pain Management;Asian Spine Journal;2021-12-30

3. Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea;Journal of Clinical Sleep Medicine;2021-10

4. Buprenorphine buccal film for chronic pain management;PAIN MANAG;2020

5. A meta-analysis of the potential antidepressant effects of buprenorphine versus placebo as an adjunctive pharmacotherapy for treatment-resistant depression;Journal of Affective Disorders;2020-06